|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01801 INNOVENT BIO
Nominal 
40.400 -0.250 (-0.615%) Ranking Overview
Ranking based on 16 research report(s)
Average Ranking 2.13
|
Strong Buy (1)
0
|
Buy (2)
14
|
Hold (3)
2
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2023 | EPS | -66.00 RMB (cts) | |
| Net Profit | -1,027.91 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2024 | -757.50 | -42.50 | 0 | -- | -422.00 | -1,097.00 |
| 2025 | 281.00 | 17.00 | 0 | -- | 615.00 | -811.00 |
| 2026 | 1,299.00 | 79.00 | 0 | -- | 2,358.00 | 220.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2024 | -475.12 | -29.00 | -- | CHINA SEC INT'L BRO | Buy | 71.92 | (6M) | 06/02/2025 |
| 2024 | -429.00 | -26.00 | -- | CITIC SEC | Buy | 70.00 | 04/11/2024 | |
| 2024 | -1,097.00 | -70.00 | -- | MORGAN STANLEY | Overweight | 66.50 | 30/10/2024 | |
| 2024 | -422.00 | -26.00 | -- | UBS | Buy | 61.40 | 13/01/2025 | |
| 2024 | -784.00 | -48.00 | -- | CICC | OutPerform | 58.00 | 04/01/2025 | |
| 2024 | -731.00 | -45.00 | -- | CMB INT'L SEC | Buy | 57.67 | 03/01/2025 | |
| 2024 | -499.00 | -32.00 | -- | CITIGROUP | Buy | 55.00 | 06/02/2025 | |
| 2024 | -896.00 | -54.78 | -- | NOMURA | Buy | 54.60 | 17/02/2025 | |
| 2024 | -1,016.20 | -25.60 | -- | UOB | Buy | 52.00 | 10/02/2025 | |
| 2024 | -819.00 | -50.00 | -- | JP MORGAN | Overweight | 50.00 | 29/10/2024 | |
| 2024 | -981.00 | -37.00 | -- | CHINA MERCHANTS | Buy | 49.00 | 28/10/2024 | |
| 2024 | -686.00 | -42.00 | -- | HSBC | Buy | 48.00 | 27/01/2025 | |
| 2024 | -812.00 | -52.90 | -- | BANK OF AMERICA | Buy | 44.00 | 18/02/2025 | |
| 2024 | -708.00 | -43.00 | -- | ZHONGTAI INT'L SEC | Buy | 43.85 | 11/02/2025 | |
| 2024 | -899.00 | -55.00 | -- | CLSA | Hold | 37.30 | 31/10/2024 | |
| 2024 | -629.30 | -40.00 | -- | MACQUARIE | Neutral | 37.00 | 29/10/2024 | |
| 2025 | 347.51 | 21.00 | -- | CHINA SEC INT'L BRO | -- | -- | 06/02/2025 | |
| 2025 | 354.00 | 22.00 | -- | CITIC SEC | -- | -- | 04/11/2024 | |
| 2025 | -811.00 | -50.00 | -- | MORGAN STANLEY | -- | -- | 30/10/2024 | |
| 2025 | 406.00 | 25.00 | -- | UBS | -- | -- | 13/01/2025 | |
| 2025 | 495.00 | 30.00 | -- | CICC | -- | -- | 04/01/2025 | |
| 2025 | 281.00 | 17.00 | -- | CMB INT'L SEC | -- | -- | 03/01/2025 | |
| 2025 | -27.00 | -1.70 | -- | CITIGROUP | -- | -- | 06/02/2025 | |
| 2025 | 205.00 | 12.51 | -- | NOMURA | -- | -- | 17/02/2025 | |
| 2025 | -32.00 | -2.00 | -- | JP MORGAN | -- | -- | 29/10/2024 | |
| 2025 | 95.00 | 6.00 | -- | HSBC | -- | -- | 27/01/2025 | |
| 2025 | 457.00 | 29.80 | -- | BANK OF AMERICA | -- | -- | 18/02/2025 | |
| 2025 | 185.00 | 11.00 | -- | ZHONGTAI INT'L SEC | -- | -- | 11/02/2025 | |
| 2025 | 615.00 | 38.00 | -- | CLSA | -- | -- | 31/10/2024 | |
| 2026 | 2,126.44 | 130.00 | -- | CHINA SEC INT'L BRO | -- | -- | 06/02/2025 | |
| 2026 | 1,411.00 | 86.00 | -- | CITIC SEC | -- | -- | 04/11/2024 | |
| 2026 | 220.00 | 14.00 | -- | MORGAN STANLEY | -- | -- | 30/10/2024 | |
| 2026 | 1,417.00 | 87.00 | -- | UBS | -- | -- | 13/01/2025 | |
| 2026 | 1,278.00 | 78.00 | 8.00 | CICC | -- | -- | 04/01/2025 | |
| 2026 | 1,299.00 | 79.00 | -- | CMB INT'L SEC | -- | -- | 03/01/2025 | |
| 2026 | 273.00 | 17.60 | -- | CITIGROUP | -- | -- | 06/02/2025 | |
| 2026 | 2,061.00 | 126.00 | -- | NOMURA | -- | -- | 17/02/2025 | |
| 2026 | 1,109.00 | 68.00 | -- | JP MORGAN | -- | -- | 29/10/2024 | |
| 2026 | 960.00 | 59.00 | 59.00 | HSBC | -- | -- | 27/01/2025 | |
| 2026 | 1,407.00 | 91.70 | -- | BANK OF AMERICA | -- | -- | 18/02/2025 | |
| 2026 | 466.00 | 28.00 | -- | ZHONGTAI INT'L SEC | -- | -- | 11/02/2025 | |
| 2026 | 2,358.00 | 144.00 | -- | CLSA | -- | -- | 31/10/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 04/03/2025 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -392,620 |
| %Change | 182.158% |
| EPS / (LPS) | RMB -0.240 |
| NBV Per Share (¥) | RMB 7.631 |